Viron Therapeutics

Development of novel therapies focused on the Membrane & Immuno-Technology' platform

Based in MA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $200K in lobbying spend across 4 quarterly filings, Viron Therapeutics is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2023.

$200K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$150K
2023$50K

Issues Lobbied

MED

Lobbying Firms

Ben Barnes Group LP

Lobbyists

Ben Barnes

Government Agencies Targeted

These are the government entities that Viron Therapeutics disclosed contacting in their lobbying filings.

Food & Drug Administration (FDA)HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED

COVID Treatment

Covid/Virus treatments

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Children's Hospital Boston
$3.4M total spend
Mass General Brigham
$2.8M total spend
Dana-farber Cancer Institute
$1.8M total spend
Revvity, INC.
$1.4M total spend
Emd Serono, INC.
$1.0M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.